« Return to News | Drug Sponsors

ISTA stockholders approve acquisition by Bausch + Lomb

Wednesday, June 6, 2012 10:05 AM

At a special meeting on Tuesday, June 5, ISTA Pharmaceuticals stockholders voted to approve the merger of ISTA and Bausch & Lomb.

The affirmative vote of the holders of a majority of the outstanding shares of ISTA's common stock was required to approve the proposal to adopt the merger agreement. According to the final tally of shares voted, 78.5% of the outstanding shares of ISTA's common stock as of the close of business on April 23, 2012, the record date, were voted to approve the proposal to adopt the merger agreement. A quorum of 79.32% of ISTA's total outstanding shares of common stock as of the April 23, 2012 record date voted at the special meeting.

The merger, initially announced on March 26, 2012, is expected to close on June 6, 2012.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.